Study guide
Drug Classifications: Controlled Substance Schedules, Mechanism-Based Categories, and Therapeutic Classes
Veterinary Technician National Examination VTNE
Track your progress as you read
Finished sections get a check mark.
1 Pharmacology Foundations and Drug Classifications
Drug Classifications: Controlled Substance Schedules, Mechanism-Based Categories, and Therapeutic Classes Pharmacokinetics: Drug Absorption, Distribution, Metabolism, and Excretion (ADME) Drug Side Effects, Adverse Reactions, Contraindications, and Drug-Drug Interactions
2 Dosage Calculations and Fluid Therapy
Dosage Calculations: mg/kg to Volume, Body Surface Area, and Metric System Conversions Fluid Therapy Rate Calculations and Continuous Rate Infusions (CRIs)
3 Medication Preparation, Dispensing, and Controlled Substances
Medication Preparation, Compounding, and Dispensing per Veterinarian Orders Controlled Drug Inventory, Logbooks, Legal Compliance, Storage, Handling, and Safe Disposal
4 Surgical Preparation and Sterile Technique
Surgical Anatomy and Pathophysiology for Perioperative Planning Surgical Environment, Equipment, and Instrument Preparation Patient Preparation: Clipping, Surgical Scrub, Draping, and Positioning Sterile Surgical Technician Role: Gowning, Gloving, and Sterile Field Maintenance
5 Instrument Processing and Aseptic Maintenance
Circulating (Non-Sterile) Technician Role, Instrument Accountability, and Count Reconciliation Instrument Cleaning Methods: Manual, Soak, and Ultrasonic Sterilization Methods, Aseptic Technique, and Surgical Suite Maintenance
6 Veterinary Dentistry
Dental Anatomy, Pathophysiology, and the Triadan Tooth-Numbering System Dental Equipment, Instruments, and Maintenance Comprehensive Oral Health Assessment and Treatment (COHAT): Scaling, Polishing, Charting, and Periodontal Assessment Dental Radiography: Positioning, Exposure, Safety, and Interpretation
7 Specimen Handling and Hematology
Specimen Collection, Preparation, Handling, Storage, and Shipping for In-House and Reference Labs Hematology: CBC Interpretation, Blood Smear Preparation, and Manual Cell Counting Cytology and Serology Procedures and Interpretation
8 Clinical Chemistry, Urinalysis, Parasitology, and Lab Quality
Clinical Chemistry, Urinalysis, Parasitology, and Microbiology Procedures Laboratory Equipment Maintenance, Calibration, Controls, and Quality Assurance
9 Patient Evaluation, Assessment, and Environment
Patient Anatomy, Physiology, and Pathophysiology for Nursing Care Initial and Ongoing Patient Evaluation: Physical Exam, Mentation, TPR, and Documentation Clinical Diagnostic Procedures: Blood Pressure Measurement, Electrocardiography, and Tonometry Safe, Sanitary, and Comfortable Environment: Housing, Hygiene, and Infection Control
10 Nursing Procedures and Treatments
Catheterization Techniques: IV, Urinary, and Feeding Tube Placement and Maintenance Wound Management and Bandaging Techniques Medication Administration: Routes (Topical, IV, SQ, IM, Oral) and Techniques
11 Specimens, Behavior, Restraint, and Equipment
Specimen Collection for In-House and Outside Laboratory Evaluation Animal Behavior Recognition and Appropriate Response Safe Animal Handling and Restraint With and Without Equipment
12 Diagnostic Imaging and Radiation Safety
Imaging Anatomy and Pathophysiology for Radiographic Interpretation Radiographic Production, Patient Positioning, and Documentation for Quality Images Imaging Equipment Maintenance, ALARA Principles, and Radiation Safety Protocols
13 Anesthesia Foundations and Planning
13.1 Anesthesia Anatomy, Physiology, and Pathophysiology 13.2 Anesthetic Plan Development and Pre-anesthetic Assessment and Care 13.3 Anesthetic Medications: Pharmacology, Reactions, Contraindications, and Interactions
14 Anesthetic Equipment and Airway Management
Anesthetic Machine Preparation, Leak Testing, and Equipment Maintenance for Reliable Operation Endotracheal Intubation: Technique, Airway Management, and Troubleshooting
15 Anesthesia Monitoring and Recovery
Anesthesia Monitoring: Pre-Anesthetic, Peri-Operative, and Post-Operative Stages (EtCO2, SpO2, HR, BP, Temperature) Anesthesia Troubleshooting, Recovery Assessment, and Post-Anesthetic Care
16 Emergency Medicine and Critical Care
Emergency Anatomy, Pathophysiology, and Triage Prioritization Emergency Nursing Procedures: RECOVER CPR, Acute Blood Loss Control, and Fracture Stabilization Critical Care Nursing: Blood Component Therapy, Fluid Resuscitation, and Ongoing Oxygen Therapy Ongoing Patient Evaluation in Emergency and Critical Conditions
17 Pain Management and Analgesia
Pain Anatomy, Physiology, and Pathophysiology Foundations Pain Recognition and Assessment: Scoring Scales and Species-Specific Behavioral Indicators Multimodal Pain Management Plans: Analgesic Selection, Contraindications, and Implementation Analgesic Administration Techniques and Reassessment Cadence
18 Communication and Veterinary Professional Support Services
Client education: animal care, risks, side effects, preventative care, and zoonosis Professional communication, ethics, veterinary team interactions, and record keeping Patient information collection, signs of animal abuse, and euthanasia assistance (consent, aftercare, grief management)
Drug Classifications: Controlled Substance Schedules, Mechanism-Based Categories, and Therapeutic Classes
Key Takeaways Explain This Topic AI
Methadone is DEA Schedule II — it has accepted veterinary use as a mu-agonist analgesic and cannot be refilled; a new prescription is required each fill.
Ketamine is DEA Schedule III; tiletamine/zolazepam (Telazol) and buprenorphine are also Schedule III with up to 5 refills in 6 months.
DEA Schedule II drugs require a Form 222 order form (or electronic equivalent) and cannot be refilled; CIIs through CVs require biennial inventory and a running dispensing log.
MDR1 (ABCB1) gene mutation in Collies and related herding breeds allows macrocyclic lactones (ivermectin, moxidectin, milbemycin) to cross the blood-brain barrier, causing neurotoxicity.
Mechanism of action predicts cross-class behavior: opioid mu-agonists cause dose-dependent respiratory depression; alpha-2 agonists cause predictable bradycardia reversible with atipamezole.
Last updated: July 2026
Veterinary drugs are organized three ways — by DEA controlled-substance schedule (CI through CV), by mechanism of action (how the drug works at the receptor or cellular level), and by therapeutic class (the condition being treated). Mastering all three lenses is essential because the VTNE pharmacy domain (13 percent of items) routinely asks you to identify a drug's schedule, recognize its mechanism, and predict its clinical effect — often in the same item.
Controlled Substance Schedules (DEA CI through CV)
The U.S. Drug Enforcement Administration (DEA) classifies drugs with abuse potential into five schedules based on accepted medical use and potential for psychological or physical dependence. Every veterinary practice that stocks any controlled substance must register with the DEA and renew that registration every three years. A credentialed veterinary technician who handles or dispenses controlled drugs must understand the schedule of each agent because schedule dictates ordering (Form 222 for CII versus the electronic equivalent), recordkeeping (running dispensing log, biennial inventory, DEA Form 41 for destruction), storage (locked, fixed-location safe with limited access), refill rules, and disposal procedures.
Schedule Accepted Medical Use? Dependence Potential Refills Allowed? Veterinary Examples
CI No accepted medical use Highest N/A — cannot be prescribed Heroin, LSD, MDMA, peyote, psilocybin — essentially not stocked in U.S. veterinary clinics
CII Accepted use, severe restrictions High (severe psychological or physical dependence) No refills ; new written or e-prescription required each fill; DEA Form 222 order form Morphine, oxymorphone, fentanyl, methadone, hydrocodone (used for canine cough), pure codeine
CIII Accepted use Moderate to low potential Up to 5 refills in 6 months Ketamine, tiletamine/zolazepam (Telazol), buprenorphine (partial opioid agonist), codeine combination products (never in cats), anabolic steroids (stanozolol, nandrolone)
CIV Accepted use Lower potential than CIII Up to 5 refills in 6 months Diazepam, midazolam, butorphanol, tramadol, phenobarbital, pentazocine
CV Accepted use Lowest — some states still schedule Refills as authorized by prescription (state law varies; many states restrict gabapentin) Loperamide, diphenoxylate/atropine (Lomotil), pregabalin, gabapentin (state-dependent)
Three operational rules technicians should internalize:
CII cannot be refilled. A new prescription (written, electronic, or oral for emergency) must be issued each time. Partial fills of a CII prescription must occur within 30 days; after that the remainder is void.
CIIIs through CVs may be refilled up to five times within six months of the original fill, after which a new prescription is required.
All controlled substances (CII through CV) require inventory and log records that can be reconciled: an initial inventory when the DEA registration begins, a biennial inventory every two years, and a running dispensing log that captures date, drug, strength, quantity, patient, prescriber, and dispensing technician. CIIs through CVs may be stored together; the DEA does not require separate safes — only secure, locked storage with limited personnel access.
A common VTNE trap: methadone is CII, not CI — its clinical use in dogs and cats as a mu-agonist analgesic places it firmly in Schedule II. Tramadol is CIV (not CIII) — it has lower abuse potential than ketamine but is still controlled. Ketamine is CIII and is one of the most frequently stocked dissociative anesthetics in small-animal practice.
Mechanism-Based Categories
Mechanism of action (MOA) describes how a drug produces its effect at the cellular or receptor level. The VTNE often asks about mechanism because it predicts cross-class behavior — once you know that acepromazine is a phenothiazine dopamine antagonist, you can predict its sedative effect, hypotensive side effect, and reptile contraindication. Major mechanism classes tested include:
Opioid receptor agonists and antagonists — mu-agonists (morphine, oxymorphone, fentanyl, hydromorphone, methadone — analgesia, dose-dependent respiratory depression); partial agonists (buprenorphine — ceiling effect on respiratory depression); agonist-antagonists (butorphanol — kappa-agonist, mu-antagonist, weak analgesic for visceral pain); pure antagonists (naloxone, naltrexone — reverse opioid overdose, opioid-induced bradycardia and respiratory depression).
Alpha-2 adrenergic agonists — dexmedetomidine and medetomidine produce profound sedation, muscle relaxation, and analgesia via central alpha-2 receptors. They cause predictable, dose-dependent bradycardia, vasoconstriction, and AV block; the specific antagonist atipamezole reverses them. Contraindicated in cardiovascular disease and in patients with compromised cardiac output.
Phenothiazine tranquilizers — acepromazine (no analgesia; causes hypotension via alpha-1 blockade; reduces seizure threshold; irreversibly bound to plastic, so never store in plastic syringes; reptiles very sensitive).
Benzodiazepines — diazepam, midazolam (GABA-A modulators; provide minimal sedation alone but enhance opioids; muscle relaxant; appetite stimulant in cats; reversible with flumazenil).
NSAIDs — inhibit cyclooxygenase (COX-1 and/or COX-2), reducing prostaglandin synthesis; provide analgesia and antipyresis; predictable renal and GI adverse effects when protective prostaglandins are suppressed.
Corticosteroids — glucocorticoid receptor agonists; anti-inflammatory, immunosuppressive; polyuria/polydipsia predictable; iatrogenic Cushing's with chronic use; must be tapered.
Beta-lactam antibiotics — penicillins and cephalosporins inhibit bacterial cell-wall synthesis (bactericidal, time-dependent); narrow to broad spectrum depending on generation.
Aminoglycosides — amikacin, gentamicin; inhibit 30S ribosomal subunit (bactericidal, concentration-dependent); nephrotoxic and ototoxic — renal values must be monitored.
Fluoroquinolones — enrofloxacin, marbofloxacin; inhibit DNA gyrase (bactericidal, concentration-dependent); cartilage damage in growing animals — avoid in young puppies/kittens and large-breed dogs under 12 months.
Macrolides — erythromycin, azithromycin; inhibit 50S subunit (bacteriostatic); useful for atypical organisms.
Antiparasitics — macrocyclic lactones — ivermectin, moxidectin, milbemycin open glutamate-gated chloride channels in nematode and arthropod neurons; MDR1 (ABCB1) gene mutation in Collies and related breeds allows these drugs to cross the blood-brain barrier, causing ataxia, tremors, seizures, and coma.
Therapeutic Classes
Therapeutic class groups drugs by the clinical problem they treat, regardless of mechanism — useful when a veterinarian orders "an antiemetic" and several mechanisms (maropitant NK1 antagonist, ondansetron 5-HT3 antagonist, metoclopramide D2 antagonist/prokinetic) are appropriate. Examples tested on the VTNE: antiemetics, antidiarrheals, laxatives/cathartics, bronchodilators, ACE inhibitors (enalapril, benazepril), beta-blockers (atenolol), calcium-channel blockers (amlodipine — first-line for feline hypertension), diuretics (furosemide loop, spironolactone potassium-sparing), anticonvulsants (phenobarbital CIV, levetiracetam, potassium bromide, imepitoin), GI protectants (famotidine H2 blocker, omeprazole PPI, sucralfate), and parasiticides (monthly heartworm preventives, flea and tick products). Recognizing the therapeutic class of an unfamiliar drug name lets you predict its clinical role even when the exact mechanism is less familiar.